Cell and Gene Therapy for Personalised Medicine (CGT4PM2027)
Cell and Gene Therapy for Personalised Medicine (CGT4PM2027) supports human health researchers in developing and validating innovative cell and gene therapies to advance personalised medicine.
Funder: European Commission
Due Dates: January 20, 2027 (Pre-proposals, 14:00 CET) | May 25, 2027 (Full proposals, 14:00 CEST)
Funding Amounts: EUR 37,000,000 total funding available
Summary: Supports human health research developing and validating innovative cell and gene therapies for personalised medicine.
Key Information: Compliance with regional/national funding regulations is mandatory; applicants should check eligibility with their funding representative before applying.
Description
The European Partnership for Personalised Medicine (EP PerMed) runs this Joint Transnational Call to support human health research on cell and gene therapies for personalised medicine. Proposals must focus on both the development and validation of an innovative, novel therapy, connecting therapeutic research with personalised medicine approaches.
The call covers somatic cell therapeutics, gene therapeutics, combined cell- and gene therapeutics, and novel biological products. Supported by the European Commission through the EU-funded EP PerMed project, it operates through cascade funding: EP PerMed runs the competition and awards and pays the funding itself.
